Related Experiment Video
Updated: Jul 15, 2025
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
Perinatal depression screening in community pharmacy: Exploring pharmacists' roles, training and resource needs using
Clara Strowel1, Camille Raynes-Greenow2, Lily Pham3
1Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. cstr8655@uni.sydney.edu.au.
International Journal of Clinical Pharmacy
|October 4, 2023
Summary
Pharmacists are accessible for perinatal depression (PND) screening, but require more training and resources. Their role in PND screening is supported by accessibility and consumer relationships, though scope of practice concerns exist.
Area of Science:
- Pharmacy Practice
- Mental Health
- Public Health
Background:
- Perinatal depression (PND) screening is recommended in primary care, including community pharmacies.
- Limited research exists on pharmacists' perspectives regarding their role in screening for perinatal mental illness.
Purpose of the Study:
- To explore pharmacists' views on their roles in PND screening.
- To identify training and resource needs for community pharmacy-based PND screening.
Main Methods:
- A questionnaire with open-ended questions was distributed to Australian pharmacists.
- Inductive content analysis was used for question responses.
- Subcategories were mapped to the Theoretical Framework of Acceptability.
Main Results:
- Pharmacists' roles in PND screening were categorized into supporting the community, the pharmacy environment, and system/policy changes.
- Training needs included content, length, and delivery methods.
- Resource needs involved adapting operating structures and developing pharmacist and consumer-specific resources.
Conclusions:
- Pharmacist acceptance of PND screening roles is influenced by accessibility and consumer relationships.
- Concerns exist regarding the scope of practice for PND screening.
- Enhanced training and resources are essential to support pharmacists in PND screening, referral, and care.
Related Concept Videos
01:25Antidepressant Drugs: Overview
534
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
534
01:30Community Based Intervention
48
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
48
01:27Depressive Disorders: Etiology
108
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
108
01:18Depression: Overview
263
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
263
01:19Pharmacovigilance
866
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
866
01:14CNS Depressants: Barbiturates and Benzodiazepines
293
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
293